Featured Event
May 16, 2012
Presentation of the Interim Report for the 1st Quarter

Share this on: delicious Digg Facebook LinkedIn Twitter Yahoo! Buzz What is this?
Contact Us Global/EU Veloxis Pharmaceuticals A/S Kogle Allé 4 DK-2970 Hørsholm Denmark Telephone: + 45 70 33 33 00 Fax: +45 36 13 03 19 info@veloxis.com US Veloxis Pharmaceuticals Inc. 499 Thornall Street, 3rd Floor Edison, New Jersey 08837 USA Telephone: +1 732-321-3200 Fax: +1 732-906-7943 info@veloxis.com   Investors Global/EU Johnny Stilou, CFO Telephone: +45 21 22 72 27 E-mail: JST@veloxis.com Veloxis Pharmaceuticals A/S Kogle Allé 4 DK-2970 Hørsholm Denmark US John Weinberg, MD, SVP Telephone: +1 732-321-3208 E-mail: JDW@veloxis.com Veloxis Pharmaceuticals Inc. 499 Thornall Street, 3rd Floor Edison, New Jersey 08837 US   Business Development Edward E. Koval, SVP Telephone: +1 (617) 784 4748 E-mail: EDK@veloxis.com Veloxis Pharmaceuticals Inc. 499 Thornall Street, 3rd Floor Edison, New Jersey 08837 US   Media and Corp. Communications Anja Leschly, VP Telephone: +45 20 55 38 18 Email: AAL@veloxis.com Veloxis Pharmaceuticals A/S Kogle Allé 4 DK-2970 Hørsholm Denmark   Human Resources & Careers Inquiries hr@veloxis.com

• ABOUT US
• MISSION & VALUES
• BUSINESS STRATEGY
• OUR HISTORY
• MANAGEMENT
• BOARD OF DIRECTORS
• SCIENTIFIC ADVISORY BOARDS
• CONTACT US
• COPYRIGHT AND LEGAL DISCLAIMER